LP
FBIO icon

LMR Partners’s Fortress Biotech FBIO Stock Holding History

LMR Partners’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,326
Closed -$30K – 1164
2022
Q3 		$30K Hold
2,326
– – ﹤0.01% 1136
2022
Q2 		$29K Buy
+2,326
New +$34.5K ﹤0.01% 1208
2019
Q4 		– Sell
-771
Closed -$16K – 444
2019
Q3 		$16K Hold
771
– – ﹤0.01% 404
2019
Q2 		$17K Buy
+771
New +$19.8K ﹤0.01% 405
2014
Q4 		– Sell
-692
Closed -$22K – 394
2014
Q3 		$22K Sell
692
-6,229
-90% -$165K ﹤0.01% 309
2014
Q2 		$178K Buy
+6,921
New +$182K 0.01% 412

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LMR Partners's FBIO Position: Q4 2022 in Review

LMR Partners sold out of Fortress Biotech (FBIO) in Q4 2022, closing a stake of 2,326 shares — an estimated $30K sold.

LMR Partners first reported a position in FBIO in Q2 2014 and held it in 6 quarters. The position peaked at $178K in Q2 2014. 49 funds tracked by Wall St. Rank hold FBIO as of Q4 2022.

  • LMR Partners reported no remaining Fortress Biotech position as of Q4 2022 after selling out during the quarter.
  • LMR Partners sold 2,326 Fortress Biotech shares in Q4 2022, an estimated $30K.
  • LMR Partners first reported a position in Fortress Biotech in Q2 2014 and held it in 6 quarters.
  • LMR Partners's Fortress Biotech position peaked at $178K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.